The inherent value of staging in the management of gynaecological cancers

dc.contributor.author	Van Aardt, M.C. (Matthys Cornelis)
dc.date.accessioned	2013-06-26T06:24:21Z
dc.date.available	2013-06-26T06:24:21Z
dc.date.issued	2013-05
dc.description.abstract	Staging can be defined as assessing the anatomical extent of the tumour. Stages are an artificial subdivision of the ongoing disease process based on the applicable anatomical landmarks. The main goals in treating patients with cancer are to improve cure rates, increase survival time and enhance quality of life. The most crucial factor pertaining to cancer outcome is the disease extent at the time of presentation. The stage of the disease is used to indicate this extent. This is essential to optimally manage the cancer patient.	en_US
dc.description.librarian	am2013	en_US
dc.description.uri	www.ogf.co.za	en_US
dc.identifier.citation	Van Aardt, MC 2013, 'The inherent value of staging in the management of gynaecological cancers', Obstetrics and Gynaecology Forum, vol. 23, no. 2, pp. 36-40.	en_US
dc.identifier.issn	1029-1962
dc.identifier.uri	http://hdl.handle.net/2263/21715
dc.language.iso	en	en_US
dc.publisher	In House Publications	en_US
dc.rights	In House Publications	en_US
dc.subject	Gynaecological cancers	en_US
dc.title	The inherent value of staging in the management of gynaecological cancers	en_US
dc.type	Article	en_US